16:20 EDT Clene (CLNN) files to sell 491,496 shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLNN:
- Clene’s CNM-Au8 Shows Promise in Parkinson’s Treatment, Justifying Buy Rating
- Clene presents preclinical data supporting CNM-Au8 for Parkinson’s disease
- Clene price target lowered to $48 from $83 at Canaccord
- Clene Inc. Reports Q2 2025 Financial Results
- Optimistic Buy Rating for Clene Amidst Regulatory Progress and Strategic Milestones in ALS Treatment